A novel human laboratory model for screening medications for alcohol use disorder

被引：0
|
作者：
Diana Ho
Brandon Towns
Erica N. Grodin
Lara A. Ray
机构：
[1] University of California,Department of Psychology
[2] Los Angeles,Department of Psychiatry and Biobehavioral Sciences
[3] University of California,undefined
[4] Los Angeles,undefined
来源：
Trials | / 21卷
关键词：
Alcohol use disorder; Medications development; Medications screening; Naltrexone; Varenicline; Clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A novel human laboratory model for screening medications for alcohol use disorder
    Ho, Diana
    Towns, Brandon
    Grodin, Erica N.
    Ray, Lara A.
    TRIALS, 2020, 21 (01)
  • [2] Alcohol Tolerance in Human Laboratory Studies for Development of Medications to treat Alcohol Use Disorder
    Haass-Koffler, Carolina L.
    Perciballi, Roberta
    ALCOHOL AND ALCOHOLISM, 2020, 55 (02): : 129 - 135
  • [3] A Practice-Quit Model for Screening Medications for Alcohol Use Disorder
    Ray, Lara
    Nieto, Steven
    Grodin, Erica
    Basker-Ville, Wave-Ananda
    Ho, Diana
    Russell, Riley
    Gillis, Artha
    Miotto, Karen
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 416 - 416
  • [4] A practice-quit model for screening medications for alcohol use disorder
    Baskerville, W.
    Nieto, S.
    Grodin, E. N.
    Ho, D.
    Russell, R.
    Gillis, A.
    Miotto, K.
    Ray, L. A.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 239 - 239
  • [5] A HUMAN LABORATORY STUDY OF MIFEPRISTONE AS A NOVEL TREATMENT FOR ALCOHOL USE DISORDER
    Mason, Barbara J.
    ALCOHOL, 2017, 60 : 224 - 224
  • [6] DEVELOPING MEDICATIONS FOR OPIOID USE DISORDER IN THE HUMAN LABORATORY
    Comer, S. D.
    Jones, J. D.
    Metz, V.
    Mogali, S.
    Manubay, J. M.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 328A - 328A
  • [7] Medications for Alcohol Use Disorder
    Poorman, Elisabeth
    McQuade, Brianna M.
    Messmer, Sarah
    AMERICAN FAMILY PHYSICIAN, 2024, 109 (01) : 71 - 78
  • [8] Medications for Alcohol Use Disorder
    Winslow, Bradford T.
    Onysko, Mary
    Hebert, Melanie
    AMERICAN FAMILY PHYSICIAN, 2016, 93 (06) : 457 - 465
  • [9] EFFECTS OF VARENICLINE IN HUMAN LABORATORY MODELS FOR SCREENING OFPHARMACOTHERAPEUTICS FOR ALCOHOL USE DISORDER.
    Vatsalya, V.
    Gowin, J. L.
    Schwandt, M. L.
    Momenan, R.
    Heilig, M.
    Bardett, S. E.
    Ramchandani, V. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S21 - S21
  • [10] Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models
    Yardley, Megan M.
    Ray, Lara A.
    ADDICTION BIOLOGY, 2017, 22 (03) : 581 - 615
12345